Your browser doesn't support javascript.
loading
Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A population-based analysis.
Tan, Wei Shen; Trinh, Quoc-Dien; Hayn, Matthew H; Marchese, Maya; Lipsitz, Stuart R; Nabi, Junaid; Kilbridge, Kerry L; Vale, Justin A; Khoubehi, Bijan; Kibel, Adam S; Sun, Maxine; Chang, Steven L; Sammon, Jesse D.
Afiliación
  • Tan WS; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Division of Surgery & Interventional Science, Department of Urology, University College London, London, United Kingdom; Department of Urology, Imperial College
  • Trinh QD; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: qtrinh@bwh.harvard.edu.
  • Hayn MH; Division of Urology, Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME.
  • Marchese M; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Lipsitz SR; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Nabi J; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Kilbridge KL; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Vale JA; Department of Urology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Khoubehi B; Department of Urology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Kibel AS; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Sun M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Chang SL; Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Sammon JD; Division of Urology, Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME.
Urol Oncol ; 38(3): 74.e13-74.e20, 2020 03.
Article en En | MEDLINE | ID: mdl-31864937
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Tiempo de Tratamiento / Neoplasias Renales / Nefrectomía Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Tiempo de Tratamiento / Neoplasias Renales / Nefrectomía Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos